AUROPHARMA in Focus: Aurobindo Pharma Share Price Hits 52-Week High, Up 4.18% on Rising Newsflow

Aurobindo Pharma share price today, and the reason behind it

Shares of Aurobindo Pharma are changing hands at ₹1,717.00 on the NSE board as of 04:35 pm IST on 31 August 2026 — +71.70 or +4.18% from the previous close of ₹1,717.00. Behind the number, the stock is printing at the top of its own twelve-month range — there is no overhead supply from earlier buyers left above this level, which is why breakouts here extend when volume follows.

Highlights

• Where it trades: Aurobindo Pharma is at ₹1,717.00, +71.70 (+4.18%) versus the previous close of ₹1,717.00.
• Why it is moving: an in-focus story — 2 business desks filed on the company in the last few hours.
• Today's band: ₹1,635.10 to ₹1,717.00, against an open of ₹1,648.60 — the stock is defending its opening print.
• Twelve-month context: -2.06% below the ₹1,682 high and 68.98% above the ₹1,016 low, so the stock sits in the upper part of its own range.
• Participation: turnover is running at 2.4x the twenty-day average, so institutions are transacting rather than retail nibbling.
• What to watch: an exchange filing from the company itself, since headline-driven moves without a disclosure behind them tend to fade within a session or two.

Why Aurobindo Pharma is on the desks today

Aurobindo Pharma is one of the most-mentioned names on the business wires right now — run by 2 publishers, with the headlines linked below. When several desks run the same company on the same day, the flow that follows is usually driven by attention rather than by a single disclosure, so the price move needs volume behind it to mean anything.

The board at a glance

How the session has traded

Aurobindo Pharma has traded between ₹1,635.10 and ₹1,717.00 in this session against an open of ₹1,648.60 and a previous close of ₹1,717.00. That is a band of ₹81.90, or 4.77% of the current price — a wide day, which means intraday positions are being forced rather than chosen.

Holding above the open at ₹1,648.60 matters because it is the level intraday desks use as the session pivot: buyers who entered at the open are in profit, so there is no forced supply from that cohort.

In market-structure terms this is a continuation session, so the prior trend remains the base case until a level breaks.

What it means when several desks run the same name

2 publishers filed on Aurobindo Pharma in the last few hours without a single dominant disclosure driving it. Clustered coverage of this kind is usually attention rather than information: a screen result, a sector read-across, or a follow-up to something filed earlier in the week. Attention brings order flow, but order flow without a disclosure behind it decays.

The way to separate the two is participation. A move on turnover at or above the stock's own recent average means positions are changing hands and the level is likely to hold. The same move on thin volume is a handful of trades and reverses easily, which is why the volume column deserves as much attention as the percentage change.

Aurobindo Pharma is at ₹1,717.00, +71.70 (+4.18%), between ₹1,635.10 and ₹1,717.00 on the day, on 2.4x its twenty-day average volume.

The longer-horizon picture

What the returns table is saying

Over the last week Aurobindo Pharma has gained +5.90% and over the month +8.93%. Both horizons pointing the same way means the recent move is an extension of the existing trend rather than a reversal.

The twelve-month return of +67.51% is the context long-term holders judge the stock on. After a run of this size, most of the easy re-rating is behind the price, so incremental gains usually have to come from delivered earnings rather than sentiment.

Reading the price against its own ranges

Over the last twelve months the price has covered ₹1,016 to ₹1,682. The current level is 105% of the way through that band, -2.06% below the 52-week high and 68.98% above the 52-week low. Trading this close to the yearly high means there is little overhead supply from earlier buyers, which is why breakouts here tend to extend — but it also leaves no cushion if the news flow turns.

Traded quantity of 24,16,718 shares is 2.43x the 20-day average of 9,95,800. Volume expansion of this order alongside a price move is the classic confirmation signal — institutions cannot build or exit positions quietly, so unusual turnover normally means larger hands are active.

What the newswires are reporting

Headlines are listed for context and link straight to the publisher. The prices, ranges and tables on this page are read independently from exchange data at the timestamp shown.

• Aurobindo Pharma gains over 3% as subsidiary launches generic Advair Diskus in US; stock up 41% YTD — Economic Times
• Aurobindo Pharma Ltd spurts 3.36%, gains for fifth straight session — Business Standard
• Aurobindo Pharma enters US inhalation market with generic Advair launch — Business Standard

What decides the next session

For this in focus story specifically, watch an exchange filing from the company itself, since headline-driven moves without a disclosure behind them tend to fade within a session or two. On the chart, the ₹1,717.00 high and ₹1,635.10 low of this session are the reference levels — a higher low in the next session turns a headline reaction into a trend, a break of today's low usually voids it. Participation is the third check: the move needs turnover at or above the stock's own 20-day average of 9,95,800 shares to be read as positioning rather than a squeeze.

How to read this as an investor

For a trader, the setup is a range breakout: the reference is today's ₹1,717.00 high, and a close above it with volume keeps the trend intact. The invalidation is equally clean — a slip back under ₹1,635.10 puts the stock back inside the range it just left, and breakouts that fail tend to retrace to the middle of that range.

For a long-term shareholder, one session tells you very little. The stock is -2.06% off its twelve-month high, so the more useful exercise is comparing that drawdown with the change in earnings over the same period: price falling faster than profits is an opportunity, the reverse is a warning.

On risk: this report is a reading of live exchange data at a point in time, and intraday levels change. Position sizing — not conviction about the story — is what determines the outcome of a trade built on a headline, and averaging into a falling price without a change in the underlying facts is how a trade becomes an unintended long-term holding.

In summary

Aurobindo Pharma is being bought on an in-focus story, and at ₹1,717.00 the move is backed by turnover well above its own average, which is the version of a rally that tends to hold. The day's ₹1,635.10–₹1,717.00 band is the frame for the next session, and an exchange filing from the company itself is what resolves the story either way.

Where to track AUROPHARMA next

Live price, charts and technicals stay on the Aurobindo Pharma stock page, and every filed quarter is tabulated on its quarterly results page. Both pages refresh from the exchange feed through the session, so they carry a later reading than this report once the market has moved on.

Frequently asked questions

What is the Aurobindo Pharma share price today?

Aurobindo Pharma (AUROPHARMA) last traded at ₹1,717.00, +71.70 (+4.18%) against the previous close of ₹1,717.00, read from the NSE board at 04:35 pm IST on 31 August 2026.

Why is Aurobindo Pharma in the news today?

2 business publishers ran headlines on the company in the last session — a in focus story. Their reports are linked above; the levels and tables here are read independently from exchange data.

What is the 52-week high and low of AUROPHARMA?

Over the last twelve months AUROPHARMA has traded between a low of ₹1,016 and a high of ₹1,682, computed from the adjusted daily series.

Is AUROPHARMA up or down today?

AUROPHARMA gained +4.18% in this session, trading between ₹1,635.10 and ₹1,717.00 against an open of ₹1,648.60.

Key takeaways

• Last price: ₹1,717.00 (+4.18%) — higher at the time of writing
• Day range: ₹1,635.10 – ₹1,717.00
• 52-week high: ₹1,682

About this report

Every figure on this page is read from a primary source at the timestamp shown — exchange boards for equities and indices, the exchange bid book for IPOs, published association rates for bullion, and consolidated exchange quotes for crypto — with no estimation or third-party commentary. Historical fields such as trailing returns and 52-week extremes are computed on the adjusted daily series so splits and bonuses do not create false gaps. A timestamp outside market hours reflects the last traded or last published value, not a live tick.

Related live pages

• Aurobindo Pharma share price
• Aurobindo Pharma quarterly results
• Stocks in news
• Top gainers
• Market dashboard

Sources

• NSE live board data via our exchange data feed
• Headline attribution links above point to the original publishers
• TrendRipperX Aurobindo Pharma stock page

“This report is generated automatically from live exchange and official association data at the time stamped above. Prices move continuously — verify on the source before acting. Nothing here is investment advice.”